Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2001 4
2002 11
2003 11
2004 8
2005 13
2006 3
2007 12
2008 9
2009 12
2010 9
2011 9
2012 16
2013 10
2014 25
2015 17
2016 24
2017 21
2018 36
2019 33
2020 37
2021 33
2022 32
2023 42
2024 33
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

426 results

Results by year

Filters applied: . Clear all
Page 1
Author reply.
Velez MP, Shellenberger JP, Ray JG. Velez MP, et al. Among authors: ray jg. BJOG. 2024 Aug;131(9):1323-1325. doi: 10.1111/1471-0528.17781. Epub 2024 Feb 13. BJOG. 2024. PMID: 38351674 No abstract available.
Pre-eclampsia and the brain.
Ray JG, Park AL. Ray JG, et al. BMJ. 2018 Oct 17;363:k4236. doi: 10.1136/bmj.k4236. BMJ. 2018. PMID: 30333102 No abstract available.
Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial.
Feig DS, Donovan LE, Zinman B, Sanchez JJ, Asztalos E, Ryan EA, Fantus IG, Hutton E, Armson AB, Lipscombe LL, Simmons D, Barrett JFR, Karanicolas PJ, Tobin S, McIntyre HD, Tian SY, Tomlinson G, Murphy KE; MiTy Collaborative Group. Feig DS, et al. Lancet Diabetes Endocrinol. 2020 Oct;8(10):834-844. doi: 10.1016/S2213-8587(20)30310-7. Lancet Diabetes Endocrinol. 2020. PMID: 32946820 Clinical Trial.
SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors.
Wing S, Ray JG, Yau K, Jeyakumar N, Abdullah S, Luo B, Cherney DZI, Harel Z, Hundemer GL, Mavrakanas TA, Molnar AO, Odutayo A, Perl J, Young A, Charytan D, Weir M, Wald R. Wing S, et al. Among authors: ray jg. JAMA Intern Med. 2025 Jul 1;185(7):827-836. doi: 10.1001/jamainternmed.2025.0686. JAMA Intern Med. 2025. PMID: 40293730
426 results